title: Regorafenib: start low and go slow.
authors.affiliation: Faculty of Medicine, Hematology Oncology Department, Saint Joseph University, Beirut, Lebanon, tabchi@hotmail.com.
authors.forename: S
authors.initials: S
authors.lastname: Tabchi
authors.forename: M
authors.initials: M
authors.lastname: Ghosn
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D017326:Clinical Trials, Phase III as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D018450:Disease Progression; D004334:Drug Administration Schedule; D041981:Gastrointestinal Tract / Q000187:drug effects; D006801:Humans; D009362:Neoplasm Metastasis; D010671:Phenylurea Compounds / Q000008:administration & dosage* / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects*; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D011725:Pyridines; C559147:regorafenib